ArticleFrontiers in oncology2022

Efficacy and safety of transarterial chemoembolization plus antiangiogenic- targeted therapy and immune checkpoint inhibitors for unresectable hepatocellular carcinoma with portal vein tumor thrombus in the real world.

Jin-Kai Feng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.